1) tenofovir disoproxil fumarate
替诺福韦酯
1.
Mutations possibly associated with tenofovir disoproxil fumarate resistance in 1740 patients with chronic hepatitis B
1740例慢性乙型肝炎患者替诺福韦酯耐药可能相关突变分析
2) Tenofovir
替诺福韦
1.
Effect of Cationic Liposome Formulation on Human Carcinoma Hepatic SMMC-7721 Cells' Uptake of Tenofovir and Cytotoxicity;
替诺福韦阳离子脂质体的制备及其对人体肝细胞SMMC-7721摄取和细胞毒性研究
2.
Study on pharmacokinetics of tenofovir disoproxil fumarate capsules in healthy volunteers;
富马酸替诺福韦酯胶囊在健康人体内的药动学研究
3.
Cationic Liposome Formulations of Tenofovir and Their Role in Enhancing Hepatocyte Uptake;
替诺福韦阳离子脂质体的制备和细胞摄取研究
3) tenofovir DF
替诺福韦DF
1.
The pharmacological ac-tions,pharmacokinetics,clinical trial and tolerance of tenofovir DF are reviewed in this article.
替诺福韦DF是替诺福韦的前药,是一种核苷酸逆转录酶抑制剂,已被美国和欧洲批准治疗人类免疫缺陷病毒(HIV)感染。
6) adefovir dipivoxil
阿德福韦酯
1.
NMR Study on New Drug of Adefovir Dipivoxil;
新药阿德福韦酯的核磁共振研究
2.
The study of the influence of Anluo Huaxian pills in combination with adefovir dipivoxil on hepatic fibrosis of chronic hepatitis B patients;
安络化纤丸联合阿德福韦酯治疗慢性乙型肝炎肝纤维化的疗效观察
3.
Therapeutic effects of Adefovir dipivoxil in combination with Thymopentin on chronic hepatitis B;
阿德福韦酯联合胸腺五肽治疗慢性乙型肝炎初探
补充资料:美替诺龙
分子式:C20H30O2
分子量:302.46
CAS号:153-00-4
性质:暂无
制备方法:暂无
用途:暂无
分子量:302.46
CAS号:153-00-4
性质:暂无
制备方法:暂无
用途:暂无
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条